FDG PET/CT imaging and circulating biomarkers of inflammation in desmoplakin cardiomyopathy
Abstract Aims Inflammation has been implicated in the pathogenesis of desmoplakin (DSP) cardiomyopathy, and retrospective studies have described abnormal myocardial fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) findings in symptomatic patients eventually diagnosed with DSP cardiomyopathy.
Sanjay Divakaran+10 more
wiley +1 more source
CD148 agonistic antibody alleviates renal injury induced by chronic angiotensin II infusion in mice. [PDF]
Takahashi K+9 more
europepmc +1 more source
Astragaloside IV Attenuates Angiotensin II-Induced Inflammatory Responses in Endothelial Cells: Involvement of Mitochondria. [PDF]
Zhang S, Li S, Cui L, Xie S, Wang Y.
europepmc +1 more source
Comparative effects of angiotensin II stimulating and inhibiting antihypertensives on dementia risk: a systematic review and meta-analysis. [PDF]
Belachew EA, Peterson GM, Bezabhe WM.
europepmc +1 more source
The renin-angiotensin-aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II. [PDF]
Legrand M+17 more
europepmc +1 more source
Prothrombotic State and Vascular Damage in Angiotensin II-Induced Hypertension: Influence of Waterpipe Smoke Exposure. [PDF]
Beegam S+4 more
europepmc +1 more source
Angiotensin Receptor Blockade Does Not Decrease Synthetic Angiotensin II (Giapreza<sup>®</sup>) Effectiveness in Perioperative Hypotension Surrounding Kidney Transplant. [PDF]
Pettit N+5 more
europepmc +1 more source
Related searches:
Angiotensin II (Ang II) is the active peptide of the renin-angiotensin system (RAS). Ang II binds to AT1 and AT2 receptors to conduct signals. In mammals, losartan and PD123319 are AT1 and AT2 receptor antagonists, respectively, but these pharmacological blockers are not effective in other vertebrates.
Marty Kwok-Shing Wong
semanticscholar +3 more sources